Venture Capital

With new CEO Dr. Hoshang Subawalla, AquaFortus pivots from R&D to global infrastructure, deploying its disruptive brine tech to rewrite water economics.

Amid market volatility, Lavior is boosting US production and launching dual product lines, a strategic move to ensure stability for clinics and consumers alike.

South Korean biotech Galux raises a major Series B round to accelerate its AI platform, which designs novel antibody drugs from scratch with high precision.

Backed by a proven billion-dollar impact model, 14 new startups are using AI, neuroscience, and philanthropy to revolutionize mental healthcare.

A new initiative backed by the Japanese government aims to transform the nation's world-class scientific research into globally competitive biotech companies.

From its unique seat at the World Government Summit, CanSinoBIO unveils its next-gen vaccine pipeline and global strategy to fight humanity's oldest diseases.

After a year-long restructuring, SVCV launches asset manager NextRock to acquire 100 companies and build a cross-industry empire from finance to fashion.

A new alliance between Tend Health and SafeHavenMD offers a confidential lifeline to doctors battling burnout, integrating peer support with clinical care.

With a new flexible, founder-first model, Activation Capital's Frontier BioHealth program aims to bridge the commercialization gap for life sciences startups.

A new deal pairs Inturai's AI sensing platform with a firm of elite special forces veterans, aiming to revolutionize intelligence for North American forces.

With a promising spinal cord injury drug nearing late-stage trials, NervGen appoints interim leader Dr. Adam Rogers as permanent CEO to guide the breakthrough.

Semiconductor leader Astera Labs launches a new R&D hub in Israel, hiring top tech veterans to develop next-gen connectivity for the demanding AI era.

Bruker divisions unveil an open, AI-driven platform at SLAS2026, aiming to unify fragmented labs and enable 24/7 autonomous scientific discovery.

A new German partnership aims to create variant-ready, room-temperature stable vaccines, moving beyond the limits of first-generation mRNA technology.

Global giant CSL taps Swiss biotech Memo Therapeutics in a landmark deal, signaling a major shift from plasma to lab-grown immunotherapies.

Key Mining Corp. is going public via a SPAC deal to fund a massive titanium project in Chile, betting on rising demand for critical minerals.

With a rare SRO license and CEO experience, Kym Harshaw's move to ZettaJoule signals a serious push to commercialize advanced high-temperature reactors.

A new Texas facility is turning oilfield wastewater into battery-grade lithium, a historic first step in America's race for critical mineral independence.

Custom rug brand Ernesta opens its first Texas showroom, betting on Dallas's design scene while its model faces praise for innovation and scrutiny over quality.

American Battery Technology Co. reports record revenue and a crucial cash flow turning point, accelerating its plans for domestic mineral recycling and mining.